These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 6188892)

  • 1. Efficacy of intravenous pirmenol hydrochloride for treatment of ventricular arrhythmias: a controlled comparison with lidocaine.
    Anderson JL; Lutz JR; Sanders SW; Nappi JM
    J Cardiovasc Pharmacol; 1983; 5(2):213-20. PubMed ID: 6188892
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy, safety, and pharmacokinetics of a concentration-maintaining regimen of intravenous pirmenol.
    Reiter MJ; Hammill SC; Shand DG; Verghese C; McCarthy E; Pritchett EL
    Am J Cardiol; 1983 Jul; 52(1):83-7. PubMed ID: 6858934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemodynamic effects of pirmenol, a new antiarrhythmic agent, assessed noninvasively.
    Toivonen LK; Nieminen MS
    Int J Cardiol; 1986 Feb; 10(2):111-8. PubMed ID: 3943931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and efficacy of pirmenol hydrochloride in the treatment of ventricular dysrhythmia.
    Lee TG; Goldberg AD; Chang T; Serkland MT; Yakatan GJ; Johnson EL; Toole JG; Goldstein S
    J Cardiovasc Pharmacol; 1983; 5(4):632-7. PubMed ID: 6193362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and tolerance of intravenous flecainide in patients with chronic high frequency ventricular arrhythmias.
    Stroobandt R; Andries E; van Mieghem W; Kesteloot H
    Eur Heart J; 1984 Nov; 5(11):876-82. PubMed ID: 6397356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute haemodynamic effects of the antiarrhythmic agent pirmenol in cardiac patients: a comparison with lidocaine.
    Nieminen MS; Toivonen LK; Manninen V; Frick MH
    Eur Heart J; 1986 Feb; 7(2):150-7. PubMed ID: 3516703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of intravenous lorcainide with lidocaine for acute therapy of complex ventricular arrhythmias: results of a randomized study with crossover option.
    Anderson JL; Anastasiou-Nana M; Lutz JR; Writer SL
    J Am Coll Cardiol; 1985 Feb; 5(2 Pt 1):333-41. PubMed ID: 3881497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of a long-acting antiarrhythmic agent--QX-572--on therapy resistant ventricular tachyarrhythmias.
    Rydén L; Hjalmarson A; Wasir H; Werkö L
    Br Heart J; 1974 Aug; 36(8):811-21. PubMed ID: 4413111
    [No Abstract]   [Full Text] [Related]  

  • 9. Preliminary study of pirmenol in the treatment of ventricular arrhythmias.
    Gimeno Gascon JV; Algarra Vidal FJ
    Am J Cardiol; 1987 Jun; 59(16):53H. PubMed ID: 3591713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigational antiarrhythmic agents: pirmenol.
    Reiter MJ; Pritchett EL
    Clin Cardiol; 1984 Jun; 7(6):330-4. PubMed ID: 6744690
    [No Abstract]   [Full Text] [Related]  

  • 11. Suppression of resistant ventricular arrhythmias by twice daily dosing with flecainide.
    Duff HJ; Roden DM; Maffucci RJ; Vesper BS; Conard GJ; Higgins SB; Oates JA; Smith RF; Woosley RL
    Am J Cardiol; 1981 Dec; 48(6):1133-40. PubMed ID: 7304461
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of hypertensive patients with ventricular arrhythmias: comparison and combination of beta-blocker and anti-arrhythmic therapy.
    Di Somma S; Savonitto S; Petitto M; Liguori V; Magnotta C; de Divitiis O
    J Int Med Res; 1989; 17(2):113-24. PubMed ID: 2498141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relation of the kinetics of pirmenol to its antiarrhythmic efficacy.
    Johnson BF; Haffajee CI; Woodman T; Sloan KL
    J Clin Pharmacol; 1988 May; 28(5):401-5. PubMed ID: 3392237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conversion of paroxysmal atrial fibrillation to sinus rhythm by intravenous pirmenol. A placebo controlled study.
    Toivonen LK; Nieminen MS; Manninen V; Frick MH
    Br Heart J; 1986 Feb; 55(2):176-80. PubMed ID: 3510642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemodynamic effects of pirmenol and lidocaine: a placebo-controlled, double-blind, comparative study.
    Nieminen MS; Toivonen L; Manninen V; Frick H
    Am J Cardiol; 1987 Jun; 59(16):27H-32H. PubMed ID: 3296728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lorcainide infusion in the treatment of ventricular premature beats (VPB).
    Klotz U; Müller-Seydlitz PM; Heimburg P
    Eur J Clin Pharmacol; 1979 Aug; 16(1):1-6. PubMed ID: 499295
    [No Abstract]   [Full Text] [Related]  

  • 17. Flecainide: a new agent for the treatment of ventricular arrhythmias.
    Grubb BP; Tilley-Gray B
    Am J Med Sci; 1986 Sep; 292(3):160-3. PubMed ID: 3529958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of acute hemodynamic effects of lidocaine and procainamide for postoperative ventricular arrhythmias in dogs.
    Chandler JC; Monnet E; Staatz AJ
    J Am Anim Hosp Assoc; 2006; 42(4):262-8. PubMed ID: 16822764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Initial and long-term outpatient experience with pirmenol for control of ventricular arrhythmias.
    Hampton EM; Anderson JL; Lutz JR; Nappi JM
    Eur J Clin Pharmacol; 1986; 31(1):15-22. PubMed ID: 3780822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of lidocaine and propranolol on the normal and anomalous pathways in patients with preexcitation.
    Rosen KM; Barwolf C; Ehsani A; Rahimtoola SH
    Am J Cardiol; 1972 Dec; 30(8):801-9. PubMed ID: 4634277
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.